Table 3.
Category / subcategory | # of discussions | |
---|---|---|
1. Adverse effects of drug therapy | 20 | |
| ||
2. Non-adherence to therapeutic and monitoring plan | 33 | |
Patient cognition | 15 † | |
Access to care and environmental constraints | 7 † | |
Patient understanding* | 2 | |
Transitions of care | 1 | |
Cross-cutting and non-specific barriers | 11 | |
| ||
3. Patient preferences | 17 | |
Patient beliefs and preferences | 15 | |
Patient understanding* | 0 | |
Cross-cutting and non-specific barriers | 2 | |
| ||
4. Co-management with other providers and health systems | 12 | |
Co-management in ongoing care | 9 | |
Transitions of care * | 3 | |
Cross-cutting and non-specific barriers | 0 | |
| ||
5. Prioritization / benefit | 20 | |
Prioritization and time limitations | 13 | |
Limited or uncertain benefit | 7 |
These subcategories are shared across more than one category. Counts are allocated to only one category, based on what was considered the “primary” category for that reason.
Three discussions included a combination of patient cognition and access / environmental issues; these discussions are counted in each of these subcategories.